Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study.

Autor: Yoshida C; Department of Hematology, National Hospital Organization Mito Medical Center, 280 Sakuranosato, Ibarakimachi, Higashiibarakigun, Ibaraki, 311-3193, Japan. c.yoshida@mitomedical.org., Yamaguchi H; Department of Hematology, Nippon Medical School, Tokyo, Japan., Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Murai K; Department of Hematology, Iwate Prefectural Central Hospital, Morioka, Japan., Iino M; Department of Medical Oncology, Yamanashi Prefectural Central Hospital, Kofu, Japan., Hatta Y; Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan., Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan., Yokose N; Department of Hematology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan., Fujimaki K; Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan., Hagihara M; Department of Hematology, EIJU General Hospital, Taito-Ku, Japan., Oshikawa G; Japanese Red Cross Musashino Hospital, Musashino, Japan., Murayama K; Division of Hematology, Gunma Prefectural Cancer Center, Ohta, Japan., Kumagai T; Department of Hematology, Ome Municipal General Hospital, Ome-Shi, Tokyo, Japan., Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan., Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Iriyama N; Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan., Tsutsumi I; Department of Hematology, National Hospital Organization Mito Medical Center, 280 Sakuranosato, Ibarakimachi, Higashiibarakigun, Ibaraki, 311-3193, Japan., Oba K; Department of Biostatistics, The University of Tokyo, Tokyo, Japan., Kojima H; Ibaraki Clinical Education and Training Center, University of Tsukuba Hospital, Kasama, Japan., Sakamaki H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Inokuchi K; Department of Hematology, Nippon Medical School, Tokyo, Japan.

Publikováno v: International journal of hematology [Int J Hematol] 2023 May; Vol. 117 (5), pp. 694-705. Date of Electronic Publication: 2023 Feb 04.

Successful Treatment of Thrombocytopenia, Anasarca, Fever, Reticulin Myelofibrosis/Renal Insufficiency, and Organomegaly Syndrome Using Plasma Exchange Followed by Rituximab in the Intensive Care Unit.

Autor: Otsuka Y; Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan., Shirakabe A; Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan., Asayama T; Department of Hepatology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan., Okazaki H; Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan., Shibata Y; Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan., Shigihara S; Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan., Sawatani T; Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan., Yokose N; Department of Hepatology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan., Asai K; Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.

Publikováno v: Journal of medical cases [J Med Cases] 2021 Dec; Vol. 12 (12), pp. 474-480. Date of Electronic Publication: 2021 Dec 02.

P036 Diagnostic utility of flow cytometry in myelodysplastic syndromes lacking conventional diagnostic markers: a prospective validation study

Autor: Ogata, K., Della Porta, M., Malcovati, L., Picone, C., Yokose, N., Matsuda, A., Yamashita, T., Tamura, H., Tsukada, J., Dan, K., Cazzola, M.

Publikováno v: In Leukemia Research 2009 33 Supplement 1:S79-S79

Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies.

Autor: Bredin, Swann¹, Decroocq, Justine², Devautour, Clément¹, Charpentier, Julien¹, Vigneron, Clara¹, Pène, Frédéric^1,3 frederic.pene@aphp.fr

Publikováno v: Annals of Intensive Care. 9/11/2024, Vol. 14 Issue 1, p1-10. 10p.

Investigating cortical hypoxia in multiple sclerosis via time‐domain near‐infrared spectroscopy.

Autor: Williams, Thomas¹ (AUTHOR) thomas.e.williams@ucl.ac.uk, Lange, Frédéric² (AUTHOR), Smith, Kenneth J.¹ (AUTHOR), Tachtsidis, Ilias² (AUTHOR), Chataway, Jeremy¹ (AUTHOR)

Publikováno v: Annals of Clinical & Translational Neurology. Sep2024, Vol. 11 Issue 9, p2372-2381. 10p.